Laurie D. Stelzer
Overview
Laurie D. Stelzer received an average of $2M in total compensation, including $362K in salary, at Halozyme Therapeutics from 2015 to 2020.
2020Halozyme TherapeuticsFormer Senior Vice President, Chief Financial Officer
2019Halozyme TherapeuticsFormer Senior Vice President, Chief Financial Officer
2018Halozyme TherapeuticsSenior Vice President and Chief Financial Officer
2017Halozyme TherapeuticsSenior Vice President and Chief Financial Officer
2016Halozyme TherapeuticsSenior Vice President and Chief Financial Officer
2015Halozyme TherapeuticsSenior Vice President and Chief Financial Officer
Source: SEC filings on March 26, 2021, March 20, 2020, March 22, 2019, March 22, 2018, and March 24, 2017.
Related executives
We found 21 more executives who work or worked at Halozyme Therapeutics.
Helen Torley
Halozyme Therapeutics
Chief Executive Officer
Masaru Matsuda
Halozyme Therapeutics
General Counsel
Michael LaBarre
Halozyme Therapeutics
Senior Vice President, Chief Technical Officer
Elaine Sun
Halozyme Therapeutics
Chief Financial Officer
Alison Armour
Halozyme Therapeutics
Former Senior Vice President, Head of Research & Development
Benjamin Hickey
Halozyme Therapeutics
Former Senior Vice President, Chief Commercial Officer
Harry Leonhardt
Halozyme Therapeutics
General Counsel
Dimitrios Chondros
Halozyme Therapeutics